We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$43B
AUM Growth
-$7.89B
(-16%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
8,577
New
1,058
Increased
2,469
Reduced
3,270
Closed
1,444
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$158M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 4 |
Boeing
BA
|
+$34.1M |
| 5 |
ARK Innovation ETF
ARKK
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$128M |
| 2 |
NVIDIA
NVDA
|
+$89M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$47.6M |
| 5 |
Biogen
BIIB
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.37% |
| 2 | Healthcare | 1.33% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Energy | 0.65% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LFLY
4976
CALL
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
| $51.1K | ﹤0.01% |
3,920
-12,575
| -76% | -$183K |
|
4977
CALL
4D Molecular Therapeutics
FDMT
$595M
| $51.1K | ﹤0.01% |
+2,300
| New | +$35.5K |
|
4978
CALL
SES AI
SES
$208M
| $51K | ﹤0.01% |
16,200
-51,400
| -76% | -$249K |
|
4979
CALL
Core Laboratories
CLB
$558M
| $50.7K | ﹤0.01% |
2,500
+2,200
| +733% | +$42.6K |
|
4980
CALL
RCM Technologies
RCMT
$205M
| $50.6K | ﹤0.01% |
+4,100
| New | +$63.9K |
|
4981
PUT
Envista
NVST
$4.56B
| $50.5K | ﹤0.01% |
+1,500
| New | +$51.3K |
|
|
CCEC
4982
CALL
Capital Clean Energy Carriers
CCEC
$1.38B
| $50.5K | ﹤0.01% |
3,700
-5,100
| -58% | -$73.4K |
|
|
CPUH
4983
PUT
DELISTED
Compute Health Acquisition Corp.
CPUH
| $50.5K | ﹤0.01% |
5,000
| – | – |
|
4984
CALL
Brunswick
BC
$5.1B
| $50.5K | ﹤0.01% |
700
+200
| +40% | +$14.2K |
|
4985
CALL
Alzamend Neuro
ALZN
$7M
| $50.4K | ﹤0.01% |
66
-69
| -51% | -$99.9K |
|
|
AAWW
4986
PUT
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $50.4K | ﹤0.01% |
500
-6,700
| -93% | -$671K |
|
4987
PUT
Darling Ingredients
DAR
$9.91B
| $50.1K | ﹤0.01% |
800
-23,200
| -97% | -$1.64M |
|
|
FOLD
4988
PUT
DELISTED
Amicus Therapeutics
FOLD
| $50.1K | ﹤0.01% |
4,100
-3,600
| -47% | -$40.5K |
|
4989
Insmed
INSM
$29.4B
| $49.9K | ﹤0.01% |
+2,498
| New | +$48.3K |
|
4990
Ciena
CIEN
$60.5B
| $49.9K | ﹤0.01% |
979
-38,479
| -98% | -$1.74M |
|
4991
Photronics
PLAB
$1.97B
| $49.9K | ﹤0.01% |
+2,964
| New | +$50.5K |
|
4992
PUT
Arbutus Biopharma
ABUS
$899M
| $49.9K | ﹤0.01% |
21,400
-6,100
| -22% | -$14.6K |
|
|
ACCD
4993
CALL
DELISTED
Accolade Inc
ACCD
| $49.9K | ﹤0.01% |
6,400
-2,400
| -27% | -$22.9K |
|
4994
Franklin Wireless
FKWL
$28.6M
| $49.7K | ﹤0.01% |
+11,141
| New | +$38.8K |
|
4995
CALL
Vishay Intertechnology
VSH
$5.29B
| $49.6K | ﹤0.01% |
2,300
-46,700
| -95% | -$986K |
|
4996
Regenxbio
RGNX
$727M
| $49.6K | ﹤0.01% |
2,187
-989
| -31% | -$22.4K |
|
|
IMGN
4997
PUT
DELISTED
Immunogen Inc
IMGN
| $49.6K | ﹤0.01% |
10,000
-26,300
| -72% | -$143K |
|
4998
The Beachbody Company
BODI
$48.2M
| $49.6K | ﹤0.01% |
1,885
+165
| +10% | +$7.16K |
|
4999
PUT
Kratos Defense & Security Solutions
KTOS
$11.8B
| $49.5K | ﹤0.01% |
4,800
-11,100
| -70% | -$110K |
|
|
BFI
5000
PUT
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $49.5K | ﹤0.01% |
39,300
+38,300
| +3,830% | +$69.7K |
|
Similar funds
SCP
RIM
Group One Trading's Q4 2022 Portfolio in Review
As of Q4 2022, Group One Trading held 8,577 positions worth $43B, down 16% from $50.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Group One Trading withdrew a net $3.97B in Q4 2022, closing 1,444 positions and reducing 3,270 holdings. Its most notable exit was Biogen, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Cigna worth $165M.
- Group One Trading's largest Q4 2022 buy was Cigna: 497,989 shares worth $165M.
- Group One Trading added most to Microsoft in Q4 2022, an estimated $62.9M increase.
- Group One Trading's biggest Q4 2022 reduction was Tesla, cutting an estimated $128M.
- Group One Trading fully exited Biogen in Q4 2022, selling an estimated $30.6M.
- Group One Trading's ten largest holdings make up 22% of its $43B portfolio in Q4 2022.
- Group One Trading opened 1,058 new positions and closed 1,444 in Q4 2022.
- Group One Trading's portfolio value fell 16% quarter-over-quarter to $43B.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.